Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
NICE Increases Options For Hyperkalemia Patients In England
Vifor’s Veltassa & AstraZeneca’s Lokelma Get Green Light
Dec 17 2019
•
By
Ian Schofield
NICE has OKd two treatments for high potassium blood levels • Source: Shutterstock
More from United Kingdom
More from Europe